Search IconSearch

TREM2 Deficiency Hinders Recovery and Phagocytosis in Virus-Induced Demyelination

Model of viral encephalomyelitis shows links with CNS recovery from inflammation and damage


New research on the brain and spinal cord immunoreceptor TREM2 has highlighted a key mechanism behind diseases associated with demyelination.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The findings, published by a Cleveland Clinic research team in the Journal of Neuroinflammation (2022;19:267), demonstrated that a reduced chance of remission in a virus-induced model of demyelinating disease is associated with a buildup of debris from demyelination, not how the body responds to the virus.

The importance of clearing myelin debris

When myelin is damaged in neurodegenerative diseases such as multiple sclerosis, the body naturally removes myelin debris to make room for repair or regeneration. The researchers discovered that after the TREM2 protein is knocked out, the process becomes dysregulated and debris begins to build up.

If the damaged myelin is not cleared and recycled, the body ultimately cannot repair itself and recover from the virus, says the study’s corresponding author, Cornelia Bergmann, PhD, of the Department of Neurosciences in Cleveland Clinic Lerner Research Institute. This could lead to continuation of symptoms and a lower chance of remission for patients affected by viruses that cause demyelination.

The Bergmann lab studies immune response to viruses in the central nervous system. The current study focused on demyelination as a consequence of viral encephalomyelitis. The researchers found that buildup of myelin debris in a viral encephalomyelitis model was due to defective phagocytosis, the process through which cells ingest, degrade and recycle damaged or dead cells, particles and abnormally accumulated cellular components.

The study further revealed that cells lacking TREM2 also abnormally express several other genes regulating phagocytic pathways and lipid metabolism.

Dr. Bergmann compares the breakdown in the process to someone failing to empty a recycle bin: if the recyclables in the bin don’t get taken somewhere to go through the recycling process, the bin fills and trash accumulates elsewhere.

Next research steps

The mechanisms in response and recovery from viral encephalomyelitis can provide insight on other demyelinating diseases, the researchers believe.

TREM2 dysfunction has already been associated with worse outcomes in nonviral models of demyelination and neurodegenerative diseases, including Alzheimer’s disease. Targeting the harmful cellular component buildup could help treat a number of demyelinating diseases such as multiple sclerosis, as well as other neurodegenerative diseases.

“Now we need to specify which components of this pathway are vital for clearing out the myelin debris — whether it’s only the absence of TREM2 specifically causing reduced removal of debris, or the dysregulation of the other sensors and molecules affected by TREM2 deficiency,” Dr. Bergmann says.

Further basic research on this pathway would reveal any potential areas for clinical intervention, she adds.


Related Articles

neuron affected by neuromyelitis optica
Novel Monoclonal Antibodies for NMOSD Show Strong Efficacy and Safety in Real-World Study

Early experience with the agents confirms findings from clinical trials

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

September 27, 2022/Neurosciences/Pediatrics
Making Pediatrics More of a Priority in Multiple Sclerosis Treatment Trials

New review makes the case for earlier pediatric enrollment and other changes

gut microbes in intestine
Cleveland Clinic, Tufts University Research Ties Gut Microbial TMAO Pathway to Chronic Kidney Disease

Large-scale joint study links elevated TMAO blood levels and chronic kidney disease risk over time

patient in ICU
Cleveland Clinic and Purdue Seek to Revolutionize Intensive Care Through AI

Investigators are developing a deep learning model to predict health outcomes in ICUs.

Multi-Ancestry Genetic Study of Parkinson’s Disease Identifies New Risk Genes in Pursuit of Novel Treatment Targets

International collaboration is most genetically diverse study of the disease to date

Noninvasive Technology Enhances Ability to Map Brain Activity to Track Behavior Change

Preclinical work promises large-scale data with minimal bias to inform development of clinical tests

Can Boosting Hydrogen Sulfide Bolster Standard-of-Care Glioblastoma Therapy to Extend Survival?

Cleveland Clinic researchers pursue answers on basic science and clinical fronts